Observational Study on Patients With Chronic Hepatitis B

A Retrospective-prospective Observational Study to Evaluate the Effect of Anti-viral Treatment on the Long-term Outcome in Patients With Chronic Hepatitis B (SEARCH-B Study)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02167503

Enrollment

10000

Registered

2014-06-19

Start date

2014-05-31

Completion date

Unknown

Last updated

2014-06-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Hepatitis B

Brief summary

The study was conducted to evaluate the effect of anti-viral treatment on long-term outcome on patients with chronic hepatitis B.

Interventions

None listed

Study design

Observational model

COHORT

Eligibility

Sex/Gender

ALL

Age

30 Years to No maximum

Healthy volunteers

Inclusion criteria

* Male or female, aged over 30 (inclusive) years of old * Patients has a history of diagnosis of chronic hepatitis B (ie. HBsAg positive for more than 6 months) * For patients with HBsAg positive, patients should be undergoing anti-viral treatment * For patients with HBsAg negative, a documented evidence of previous anti-viral treatment should be provided. * Life expectancy is more than 1 year * Good treatment compliance.

Exclusion criteria

* Patients has a history of diagnosis of hepatocellular carcinoma * Patients with Child Pugh C * Coinfected with HCV, HDV and HIV * Suffering from other serious disease * Taking part in other clinical trial

Design outcomes

Primary

Measure	Time frame
Cumulative rates of hepatocellular carcinoma	Year 5

Countries

China

Contacts

Primary ContactJinlin Hou, MD

jlhousmu@163.com86-20-61641941

Backup ContactJian Sun, MD

doctorsunjian@163.com86-20-62787432

Outcome results